Loading Page
Dr. Aaron Thomas Chin, MD is a pediatric allergist and immunologist in Santa Monica, CA specializing in pediatric allergy & immunology and adult allergy & immunology. Dr. Aaron Thomas Chin, MD is affiliated with UCLA Health, UCLA Mattel Children's Hospital and UCLA Santa Monica Medical Center.
UCLA Santa Monica Medical Center
He completed residency at Baylor College of Medicine Affiliated Hospitals. He is certified by the Internal Medicine, American Board of Internal Medicine and has a state license in California.
Residency: Baylor College of Medicine Affiliated Hospitals (2022)
Board Certification: Internal Medicine, American Board of Internal Medicine (2022)
Licensed In: California
Dr. Aaron Thomas Chin, MD is associated with these hospitals and organizations:
Dr. Aaron Thomas Chin, MD appears to accept the following insurance providers: Cigna, Private Healthcare Systems (PHCS), TRICARE, Aetna, Blue Shield of California, MultiPlan, UnitedHealthcare, Anthem, Medicare Advantage, Prime Health, First Health, HealthSmart, Centivo, Health Net of California and UFCM Health System.
According to our sources, Dr. Aaron Thomas Chin, MD accepts the following insurance providers:
Dr. Aaron Thomas Chin, MD does not have any reviews yet, be the first to leave a review of Dr. Aaron Thomas Chin, MD here: Leave a Review
These charts describe general payments received by Dr. Aaron Thomas Chin, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$322
DUPIXENT $185 |
$137 |
|
|
$241
Ruconest $124 |
JOENJA $117 |
|
|
$152
Xembify $152 |
||
|
$133
Cinryze $118 |
HYQVIA $14 |
| $849 |
Dr. Aaron Chin practices pediatric allergy & immunology and adult allergy & immunology. His residency was performed at a hospital affiliated with Baylor College of Medicine. Dr. Chin appears to be an in-network provider for Anthem, UnitedHealthcare, Blue California, and more. He is affiliated with UCLA Mattel Children's Hospital. His practice in Los Angeles, CA is open to new patients as reported by UCLA Health.
